Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension
- 1 August 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal Of Hypertension
- Vol. 27 (8), 1672-1678
- https://doi.org/10.1097/hjh.0b013e32832be5f9
Abstract
Objective A sustained blood pressure elevation is associated with an increased risk of new-onset diabetes mellitus. Whether this is the case also in white-coat and masked hypertension is unknown. Methods In 1412 individuals of the Pressioni Arteriose Monitorate E Loro Associazioni study stratified for sex and age decades, we measured office, home and 24-h ambulatory blood pressure together with fasting plasma glucose and other metabolic variables. This allowed to identify patients with white-coat, masked, sustained hypertension and true normotension. Results Over a 10-year period, the increase in plasma glucose and the incidence of new-onset diabetes (plasma glucose ≥126 mg/dl or use of antidiabetic drugs) was significantly greater in individuals with white-coat and masked hypertension than in those with ‘true’ normotension (age and sex-adjusted risk 2.9 and 2.7, respectively), the increase being similar to that of sustained hypertensive individuals. The adjusted risk showed a marked increase when development of an impaired fasting glucose condition was also considered, and the results were similar when individuals reporting antihypertensive drug treatment were excluded or white-coat and masked hypertension were identified by office versus home blood pressure. The increased risk of new-onset diabetes become no more significant when data were adjusted for initial blood glucose and BMI, which, at a multivariate analysis, were the most significant predictors of this condition, with only a small although significant contribution of the initial blood pressure. Conclusion Thus, white-coat and masked hypertension are associated with a long-term greater progression of blood glucose abnormalities and an increased risk of developing diabetes. This is largely accounted for by the metabolic abnormalities that are frequent components of these conditions.Keywords
This publication has 28 references indexed in Scilit:
- Target Organ Damage in "White Coat Hypertension" and "Masked Hypertension"American Journal of Hypertension, 2008
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- Masked Hypertension and Target Organ Damage in Treated Hypertensive PatientsAmerican Journal of Hypertension, 2006
- Masked Hypertension and White-Coat Hypertension: Therapeutic Navigation Between Scylla and CharybdisJournal of the American College of Cardiology, 2005
- White-coat and masked hypertension in children: association with target-organ damagePediatric Nephrology, 2005
- Prevalence, Persistence, and Clinical Significance of Masked Hypertension in YouthHypertension, 2005
- Alterations of Cardiac Structure in Patients With Isolated Office, Ambulatory, or Home HypertensionCirculation, 2001
- Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: comparison with normotensives and sustained hypertensivesBlood Pressure Monitoring, 2000
- Prognostic significance of the white coat effect.Hypertension, 1997
- White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next?Journal Of Hypertension, 1996